APA

Andrade-Pavón D., Cuevas-Hernández R. I., Trujillo-Ferrara J. G., Hernández-Rodríguez C., Ibarra J. A. & Villa-Tanaca L. (20170908). Recombinant 3-Hydroxy 3-Methyl Glutaryl-CoA Reductase from Candida glabrata (Rec-CgHMGR) Obtained by Heterologous Expression, as a Novel Therapeutic Target Model for Testing Synthetic Drugs. : Applied biochemistry and biotechnology.

Chicago

Andrade-Pavón Dulce, Cuevas-Hernández Roberto I, Trujillo-Ferrara José G, Hernández-Rodríguez César, Ibarra J Antonio and Villa-Tanaca Lourdes. 20170908. Recombinant 3-Hydroxy 3-Methyl Glutaryl-CoA Reductase from Candida glabrata (Rec-CgHMGR) Obtained by Heterologous Expression, as a Novel Therapeutic Target Model for Testing Synthetic Drugs. : Applied biochemistry and biotechnology.

Harvard

Andrade-Pavón D., Cuevas-Hernández R. I., Trujillo-Ferrara J. G., Hernández-Rodríguez C., Ibarra J. A. and Villa-Tanaca L. (20170908). Recombinant 3-Hydroxy 3-Methyl Glutaryl-CoA Reductase from Candida glabrata (Rec-CgHMGR) Obtained by Heterologous Expression, as a Novel Therapeutic Target Model for Testing Synthetic Drugs. : Applied biochemistry and biotechnology.

MLA

Andrade-Pavón Dulce, Cuevas-Hernández Roberto I, Trujillo-Ferrara José G, Hernández-Rodríguez César, Ibarra J Antonio and Villa-Tanaca Lourdes. Recombinant 3-Hydroxy 3-Methyl Glutaryl-CoA Reductase from Candida glabrata (Rec-CgHMGR) Obtained by Heterologous Expression, as a Novel Therapeutic Target Model for Testing Synthetic Drugs. : Applied biochemistry and biotechnology. 20170908.